# Genetic Susceptibility to Factor VIII Inhibitors

> **NCT00344435** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 1187 (actual)

## Conditions studied

- Hemophilia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00344435
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05-24
- **Primary completion:** —
- **Final completion:** 2016-04-05
- **Target enrollment:** 1187 (ACTUAL)
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00344435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00344435, "Genetic Susceptibility to Factor VIII Inhibitors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00344435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*